Imidazolidin-2-one derivatives as selective androgen...

Details Imidazolidin-2-one derivatives as selective androgen... Imidazolidin-2-one derivatives as selective androgen...

2011-06-28

2011-06-28

Mckane, Joseph K. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S316400

Reexamination Certificate

active

07968580

ABSTRACT:
The present invention is directed to novel imidazolidin-2-one derivatives having a structure according to Formula Iwherein a, b, R1, R2, R3, and R4are as defined above, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.

REFERENCES:
patent: 4097578 (1978-06-01), Perronnet et al.
patent: 5750553 (1998-05-01), Claussner et al.
patent: 2005/0203078 (2005-09-01), Priepke et al.
patent: 2649925 (1977-05-01), None
patent: 2715402 (1995-07-01), None
patent: 2724169 (1996-03-01), None
patent: WO 2005/082895 (2005-09-01), None
Ferm, Robert J. et al. “Synthesis of 2-imidazolines and 2-imidazolidones,” Dept. of Chem., University of New Mexico, 1951. pp. 181-183.
Kim, Taek Hyeon et al. article in J. Organic Chemistry, vol. 64(8), pp. 2941-2943, 1999.
CAPLUS abstract of Schoellkopf, Ulrich et al. Accession No. 1980:495190.
CAPLUS abstract of Schoellkopf, Ulrich et al. Accession No. 1980:495190., published 1980.
Basaria, S. et al.: Anabolic-Androgenic Steroid Therapy in the Treatment of Chronic Diseases, The J. of Clin. Endocrinology & Metabolism 2001 86(11), pp. 5108-5117.
Goubet, Francois et al. “Conversion of a Thiohydantoin to the Corresponding Hydantoin via a Ring-Opening/Ring Closure Mechanism”. Tetrahedron Letters, 37(43), pp. 7727-7730, 1996. XP004030953.
Kim, Taek Hyeon et al. “Regiocontrolled Cyclization Reaction of N-(2-Hydroxyethyl)ureas by Transfer of Activation: One-Pot Synthesis of 2-Imidazolidinones”. Journal of Organic Chemistry, 64(8), pp. 2941-2943, 1999. XP002374766.
Newling, D.W.W.: Anti-androgens in the treatment of prostate cancer, British J. of Urology (1996), 77, pp. 776-784.
Schollkopf, U. et al. “Syntheses with α-Metalated Isocyanides, XLV1).—Reactions of α-Metalated Isocyanides with Some 1,3-Dipoles.” Liebigs Ann. Chem. 1980 (4) pp. 600-610.
Shahidi, N.T., MD.: A Review of the Chemistry, Biological Action, and Clinical Applications of Anabolic-Androgenic Steroids; Clinical Therapeutics, (2001) vol. 23, No. 9, pp. 1355-1391.
Bundgaard, H., “Design of Prodrugs”, (1985), Table of Contents.
McOmie, J., “Protective Groups in Organic Chemistry”, (1973) Title Page and Table of Contents.
T.W. Greene & P.G.M. Wutz (eds.), Protective Groups in Organic Synthesis, 2ndedition, Wiley Interscience, (1991), pp. 473.

Affiliated with

Also associated with

Rating

Imidazolidin-2-one derivatives as selective androgen... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazolidin-2-one derivatives as selective androgen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolidin-2-one derivatives as selective androgen... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2689661